← FDA Drug Approvals (Drugs@FDA)

SUGAMMADEX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS · Approved 2025-09-18

Drug application

FDA Application #
ANDA214319
Application type
Abbreviated New Drug Application (Generic)
Brand name
SUGAMMADEX
Generic name
Sugammadex
Active ingredients
SUGAMMADEX
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
None (Tentative Approval)
Sponsor
SUN PHARM INDS
First approval
2025-09-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown